Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
CNY 4.92
(-2.38%)
CNY 4.92
(-2.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 15.5 Million | 31.27 Million | -84.25 Million | 154.12 Million | 32.99 Million | 52.74 Million |
| Net Income | -147.28 Million | -14.93 Million | -23.03 Million | 98.28 Million | 25.15 Million | 36.8 Million |
| Depreciation & Amortization | 54.66 Million | 41.61 Million | 29.03 Million | 20.3 Million | 12.78 Million | 10.91 Million |
| Deferred income taxes | -1.6 Million | -14.57 Million | -9.83 Million | -4.04 Million | -1.73 Million | 540.32 Thousand |
| Stock-based compensation | - | - | 10.97 Million | 3.65 Million | - | - |
| Change in working capital | -7.47 Million | -19.56 Million | -137.03 Million | -23.33 Million | -21.32 Million | 2.83 Million |
| Other non-cash items | 115.6 Million | 24.16 Million | 45.65 Million | 59.25 Million | 16.37 Million | 2.19 Million |
| Investing Cash Flow | -16.35 Million | -181.41 Million | -225.38 Million | -76.21 Million | -25.94 Million | -73.5 Million |
| Investments in PPE | -66.15 Million | -146.15 Million | -211.75 Million | -123.29 Million | -56.36 Million | -77.75 Million |
| Acquisitions | 938.95 Thousand | 70.79 Thousand | 88 Thousand | 1.00 | 67.03 Million | 78.8 Million |
| Investment purchases | -938.95 Thousand | -70.79 Thousand | -20 Million | -100 Million | -315.95 Million | -170 Million |
| Sales/Maturities of investments | 6.86 Million | 6.67 Million | 6.28 Million | 147.1 Million | 277.76 Million | 173.21 Million |
| Other Investing Activities | 42.93 Million | -41.92 Million | 0.82 | -26 Thousand | 1.56 Million | -77.75 Million |
| Financing Cash Flow | -57.7 Million | 125.53 Million | 124.67 Million | 59.24 Million | -41.37 Million | -21.46 Million |
| Debt repayment | -638.17 Million | -836.36 Million | -618.63 Million | -509.28 Million | -386.65 Million | -265 Million |
| Dividends payments | -21.63 Million | -18.6 Million | -33.77 Million | -8.45 Million | -20.8 Million | -21.46 Million |
| Common Stock Repurchased | - | - | -1.4 Million | - | - | - |
| Common Stock Issuance | - | - | 1.4 Million | - | - | - |
| Other Financing Activities | -432 Thousand | 980.5 Million | 790.4 Million | 584.36 Million | 372.65 Million | 265 Million |
| Accounts receivables | -23.23 Million | -33.76 Million | -16.84 Million | -46.66 Million | -9.8 Million | 13.05 Million |
| Accounts payables | 17.74 Million | 105.61 Million | 2.78 Million | 38.54 Million | 8.16 Million | -11.51 Million |
| Inventory | -378.99 Thousand | -76.84 Million | -113.14 Million | -11.16 Million | -17.94 Million | 762.65 Thousand |
| Other working capital | -1.6 Million | -14.57 Million | -9.83 Million | -4.04 Million | -1.73 Million | 2.07 Million |
| Cash at beginning of period | 98.53 Million | 123.99 Million | 312.7 Million | 188.66 Million | 223.31 Million | 258.32 Million |
| Cash at end of period | 39.8 Million | 98.53 Million | 123.99 Million | 312.7 Million | 188.66 Million | 223.31 Million |
| Capital Expenditure | -66.15 Million | -146.15 Million | -211.75 Million | -123.29 Million | -56.36 Million | -77.75 Million |
| Effect of forex changes on cash | -184.04 Thousand | -848.1 Thousand | -3.76 Million | -13.11 Million | -321.52 Thousand | 7.2 Million |
| Net cash flow / Change in cash | -58.73 Million | -25.45 Million | -188.71 Million | 124.04 Million | -34.64 Million | -35.01 Million |
| Free Cash Flow | -50.65 Million | -114.87 Million | -296 Million | 30.83 Million | -23.36 Million | -25 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.33 Million | -718.6 Thousand | 1.74 Million | -154.67 Million | -147.28 Million | -637.75 Thousand |
| Depreciation & Amortization | - | 13.97 Million | 13.97 Million | 13.93 Million | 54.66 Million | -26.57 Million |
| Deferred income taxes | - | - | - | - | -1.6 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -34.96 Million | - | -23.61 Million | -7.47 Million | 12.42 Million |
| Other non-cash items | 17.54 Million | 26.28 Million | -10.03 Million | 292.06 Million | 115.6 Million | -12.52 Million |
| Investing Cash Flow | -11.47 Million | 5.46 Million | -14.35 Million | -35.87 Million | -16.35 Million | -13.81 Million |
| Investments in PPE | -18.04 Million | 5.17 Million | -14.35 Million | -36.65 Million | -66.15 Million | -20.67 Million |
| Acquisitions | -283.98 Thousand | 283.98 Thousand | - | 769.2 Thousand | 938.95 Thousand | - |
| Investment purchases | - | - | - | -769.2 Thousand | -938.95 Thousand | - |
| Sales/Maturities of investments | - | - | - | 10.79 Thousand | 6.86 Million | - |
| Other Investing Activities | 6.85 Million | 283.98 Thousand | - | 769.2 Thousand | 42.93 Million | 6.85 Million |
| Financing Cash Flow | -23.13 Million | 58.01 Million | -307.06 Thousand | -114.63 Million | -57.7 Million | 64.85 Million |
| Debt repayment | -21.6 Million | -62.47 Million | -1.71 Million | -84.58 Million | -638.17 Million | -185.01 Million |
| Dividends payments | - | -4.46 Million | -2.02 Million | -13.81 Million | -21.63 Million | -2.23 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -23.13 Million | -4.46 Million | -2.02 Million | -13.81 Million | -432 Thousand | 252.1 Million |
| Accounts receivables | - | -18.79 Million | - | -23.23 Million | -23.23 Million | 18.28 Million |
| Accounts payables | - | - | - | - | 17.74 Million | - |
| Inventory | - | -16.17 Million | - | -378.99 Thousand | -378.99 Thousand | -5.85 Million |
| Other working capital | - | - | - | - | -1.6 Million | - |
| Cash at beginning of period | 131.04 Million | 54.46 Million | 95.67 Million | 63.86 Million | 98.53 Million | 42.1 Million |
| Cash at end of period | 67.6 Million | 131.04 Million | 54.46 Million | 39.8 Million | 39.8 Million | 63.86 Million |
| Capital Expenditure | -18.04 Million | 5.17 Million | -14.35 Million | -36.65 Million | -66.15 Million | -20.67 Million |
| Effect of forex changes on cash | - | 2.01 Million | 550.01 Thousand | -1.26 Million | -184.04 Thousand | -1.96 Million |
| Net cash flow / Change in cash | -63.44 Million | 76.57 Million | -41.2 Million | -24.06 Million | -58.73 Million | 21.76 Million |
| Free Cash Flow | -14.84 Million | 16.77 Million | -22.65 Million | 91.05 Million | -50.65 Million | -47.98 Million |
002920
600654
1608
GURN
0976
GSF